Showing results (91-100 of 2,537) with videos related to

Sort By:
Pageof 254
Drug Testing and Analysis|September 5, 2022
Pharmacokinetics of freebase nicotine and nicotine salts following subcutaneous administration in male ratsShulei Han, Chuan Liu, Huan Chen, et al.
Drug Testing and Analysis|September 12, 2022
The importance of harmful and potentially harmful constituents in the implementation of the 2009 US Family Smoking Prevention and Tobacco Control ActJames Solyst
Drug Testing and Analysis|December 13, 2021
Defining the specificity of recombinant human erythropoietin confirmation in equine samples by liquid chromatography-tandem mass spectrometryMark Timms, Rohan Steel
Drug Testing and Analysis|January 20, 2022
Nontarget screening of production waste samples from Leuckart amphetamine synthesis using liquid chromatography - high-resolution mass spectrometry as a complementary method to GC-MS impurity profilingMaximilian Greif, Niklas Köke, Michael Pütz, et al.
Drug Testing and Analysis|March 24, 2021
Analytical strategy for the detection of ecdysterone and its metabolites in vivo in uPA(+/+)-SCID mice with humanized liver, human urine samples, and estimation of prevalence of its use in anti-doping samplesSouhail Kraiem, Maneera Y Al-Jaber, Hana Al-Mohammed, et al.
Drug Testing and Analysis|March 9, 2021
Analysis of seized peptide and protein-based doping agents using four complimentary methods: Liquid chromatography coupled with time of flight mass spectrometry, liquid chromatography-ultraviolet, Bradford, and immunoassaysLars Jakobsen Høj, Brian Schou Rasmussen, Petur Weihe Dalsgaard, et al.
Drug Testing and Analysis|October 17, 2022
N,N-Diformylmescaline: A novel analogue of mescaline detected in QueenslandRyan Gallagher, Maddison G McLaughlin, Karen Blakey, et al.
Drug Testing and Analysis|October 21, 2022
In vitro degradation of ziprasidone in human whole bloodJared W Castle, Danielle M Butzbach, G Stewart Walker, et al.
Drug Testing and Analysis|October 7, 2022
A comprehensive UHPLC-MS/MS method for the analysis of endogenous and exogenous steroids in serum for anti-doping purposesTobias Langer, Olivier Salamin, Raul Nicoli, et al.
Drug Testing and Analysis|October 1, 2022
PEth 16:0/18:1 and 16:0/18:2 after consumption of low doses of alcohol-A contribution to cutoff discussionNadine Aboutara, Hilke Jungen, Anne Szewczyk, et al.
Pageof 254